Company Filing History:
Years Active: 2025
Title: Amanda Mathis: Innovator in SARS-CoV-2 Treatment
Introduction
Amanda Mathis is a prominent inventor based in Raleigh, NC (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of viral infections. Her innovative work has led to the development of a patent that addresses the urgent need for effective therapies against SARS-CoV-2.
Latest Patents
Amanda Mathis holds a patent for "Methods, compositions, and dosing regimens for treatment of SARS-CoV-2 infections." This patent includes compounds that are designed to treat or suppress SARS-CoV-2 infections in subjects. The invention provides a novel dosing regimen that includes at least one loading dose and at least one maintenance dose of the disclosed compound. The compounds are characterized by favorable pharmacokinetics for the active pharmaceutical ingredient, particularly when used in conjunction with the described dosing regimen. Amanda has 1 patent to her name.
Career Highlights
Amanda Mathis is currently associated with Island Pharmaceuticals Ltd., where she continues to advance her research and development efforts. Her work is crucial in the ongoing fight against viral infections, and she is recognized for her innovative approaches in the pharmaceutical industry.
Collaborations
Amanda collaborates with William P. Sheridan, who is also involved in the research and development efforts at Island Pharmaceuticals Ltd. Their partnership enhances the potential for groundbreaking advancements in the treatment of viral infections.
Conclusion
Amanda Mathis is a dedicated inventor whose work in developing treatments for SARS-CoV-2 showcases her commitment to improving public health. Her innovative contributions are paving the way for new therapeutic options in the fight against viral infections.